Impact of ocular surface symptoms on quality of life in a United States veterans affairs population

American Journal of Ophthalmology
Bozorgmehr PouyehAnat Galor

Abstract

To evaluate the impact of ocular surface symptoms on quality of life in a veteran population receiving eye care services. Cross-sectional survey study. setting: Miami Veterans Affairs Medical Center (VAMC). patient population: Patients seen at the eye clinic between June and August 2010 were asked to fill out the Dry Eye Questionnaire 5 (DEQ5) and the Impact of Dry Eye on Everyday Life (IDEEL) questionnaire. main outcome measures: Correlation between ocular surface symptoms and functionality. Four hundred eighty-nine patients elected to fill out the DEQ5 questionnaire (36% response rate). The mean age of respondents was 66 years (standard deviation 12). Ninety-four percent were male; 62% were white and 37% were black. Using the DEQ5 as a surrogate measure of ocular surface symptoms, 65% of respondents reported at least mild ocular surface symptoms (DEQ5 ≥6) and 27% of them reported severe symptoms (DEQ5 ≥12). Black subjects had a 2-fold increased risk of severe symptoms compared to white subjects (odds ratio 2.06, 95% confidence interval 1.33-3.19). Several medications were associated with a significantly increased risk of severe symptoms, including glaucoma medications (1.7-fold increase), antidepressants (2.3-fold increase), ...Continue Reading

References

Dec 24, 1997·American Journal of Ophthalmology·O D ScheinS West
Jun 17, 1998·Ophthalmology·C A McCartyH R Taylor
Sep 12, 2000·Archives of Ophthalmology·S E MossB E Klein
Jul 18, 2003·Ophthalmology·Rhett M SchiffmanWalton Sumner
Dec 30, 2004·Investigative Ophthalmology & Visual Science·Polyxane MertzanisCarolyn Begley
Apr 5, 2005·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Krithika RajagopalanTimothy Edrington
Jun 9, 2005·Archives of General Psychiatry·Ronald C KesslerEllen E Walters
Feb 24, 2007·American Journal of Ophthalmology·Biljana MiljanovićDebra A Schaumberg
Aug 16, 2008·Journal of Glaucoma·Eamon W LeungRobert N Weinreb
Jan 23, 2010·Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association·Robin L ChalmersBarbara Caffery
Jun 21, 2011·American Journal of Ophthalmology·Anat GalorVictor L Perez

❮ Previous
Next ❯

Citations

Jul 25, 2013·Experimental Eye Research·Alison M McDermott
Sep 10, 2013·The British Journal of Ophthalmology·Antoine LabbéLiang Xu
Feb 7, 2013·Investigative Ophthalmology & Visual Science·Anat GalorVictor L Perez
Sep 17, 2013·Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association·Robin Chalmers
Apr 4, 2014·Graefe's Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie·Yureeda QaziPedram Hamrah
Dec 24, 2014·Ocular Immunology and Inflammation·Marjan FaridLbachir BenMohamed
Nov 5, 2013·American Journal of Ophthalmology·Miki UchinoKazuo Tsubota
Nov 28, 2015·Ophthalmology·Jeffrey P LienertDebra A Schaumberg
Apr 16, 2013·The Ocular Surface·Srihari NarayananAlison M McDermott
Apr 29, 2015·Ophthalmology·Naresh KumarAnat Galor
Jan 1, 2015·Expert Review of Ophthalmology·Anat GalorConstantine D Sarantopoulos
Oct 2, 2014·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Li Li TanRobert A Straughan
Jul 1, 2015·Drugs & Aging·Nisreen S EzuddinAnat Galor
Mar 5, 2015·Contact Lens & Anterior Eye : the Journal of the British Contact Lens Association·Andrew CampAnat Galor
Oct 15, 2013·The British Journal of Ophthalmology·Suzanne W van LandinghamPradeep Y Ramulu
May 7, 2013·Ophthalmology·Ashley M CraneAnat Galor
May 20, 2014·Experimental Eye Research·Qinxiang ZhengWei Chen
May 26, 2016·The Ocular Surface·Stefano BarabinoElisabeth M Messmer
Sep 18, 2015·The British Journal of Ophthalmology·Anat GalorRoy C Levitt
Mar 2, 2016·Eye & Contact Lens·Jerry P KalangaraElizabeth R Felix
Mar 30, 2018·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Ngamkae RuangvaravateRatchadaporn Tantimala
Aug 18, 2017·Molecular Pain·Alexandra E LevittRoy C Levitt
Jul 28, 2016·The British Journal of Ophthalmology·Priya M MathewsEsen K Akpek
Jun 6, 2018·International Ophthalmology Clinics·Kristin Schmid Biggerstaff, Albert Lin
Jun 6, 2018·International Ophthalmology Clinics·Michael Banitt, Hoon Jung
Aug 28, 2017·The British Journal of Ophthalmology·Charity J LeeAnat Galor
Feb 10, 2017·Eye & Contact Lens·Anat GalorDouglas M Wallace
Dec 12, 2017·Eye & Contact Lens·Victoria S ChangAnat Galor
Nov 16, 2018·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Sezen KarakusEsen K Akpek
Jun 25, 2019·International Ophthalmology Clinics·Anika Tandon, Marc Dinkin
Dec 10, 2013·Optometry and Vision Science : Official Publication of the American Academy of Optometry·Barbara CafferyG Lynn Mitchell
Apr 20, 2019·The British Journal of Ophthalmology·Fani SegevAlon Harris
Mar 21, 2020·Neuromodulation : Journal of the International Neuromodulation Society·Kristen ZayanAnat Galor
May 30, 2019·Eye and Vision·Xupeng ShuLiang Hu
Jun 6, 2020·Ophthalmology and Therapy·Divy MehraAnat Galor
Jun 10, 2020·European Journal of Ophthalmology·Khayam NaderiDavid O'Brart

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.